A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential

J Basha, NM Goudgaon - Journal of Molecular Structure, 2021 - Elsevier
Pyrimidines are nitrogen-containing heterocycles known for anticancer, anti-HIV, antifungal,
and antibacterial activities. Pyrimidines, compounds bearing this heterocycle, are common …

[HTML][HTML] Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors

R Bivacqua, M Barreca, V Spanò, MV Raimondi… - European Journal of …, 2023 - Elsevier
Viruses have been recognized as the etiological agents responsible for many pathological
conditions ranging from asymptomatic infections to serious diseases, even leading to death …

[HTML][HTML] Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus

Z Xu, X Liu, X Ma, W Zou, Q Chen, F Chen, X Deng… - Cell insight, 2022 - Elsevier
Annual and sporadic influenza outbreaks pose a great threat to human health and the
economy worldwide. Moreover, the frequent mutation of influenza viruses caused by antigen …

Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H

JX Kang, GK Zhao, XM Yang, MX Huang… - European Journal of …, 2023 - Elsevier
Reverse transcriptase (RT) plays an indispensable role in the replication of human
immunodeficiency virus (HIV) through its associated polymerase and ribonuclease H …

1, 2, 4-Triazolo [1, 5-a] pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors

MC Pismataro, T Felicetti, C Bertagnin, MG Nizi… - European Journal of …, 2021 - Elsevier
In the search for new anti-influenza virus (IV) compounds, we have identified the 1, 2, 4-
triazolo [1, 5-a] pyrimidine (TZP) as a very suitable scaffold to obtain compounds able to …

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization

B Mercorelli, J Desantis, M Celegato, A Bazzacco… - Antiviral research, 2022 - Elsevier
Two years after its emergence, SARS-CoV-2 still represents a serious and global threat to
human health. Antiviral drug development usually takes a long time and, to increase the …

[HTML][HTML] Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins

L Hou, Y Zhang, H Ju, S Cherukupalli, R Jia… - … Pharmaceutica Sinica B, 2022 - Elsevier
Influenza is an acute respiratory infectious disease caused by the influenza virus, affecting
people globally and causing significant social and economic losses. Due to the inevitable …

Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization

A Bonomini, T Felicetti, M Pacetti, C Bertagnin… - European Journal of …, 2024 - Elsevier
Influenza viruses (IV) are single-stranded RNA viruses with a negative-sense genome and
have the potential to cause pandemics. While vaccines exist for influenza, their protection is …

Privileged scaffolds for potent and specific inhibitors of mono-ADP-ribosylating PARPs

MG Nizi, C Sarnari, O Tabarrini - Molecules, 2023 - mdpi.com
The identification of new targets to address unmet medical needs, better in a personalized
way, is an urgent necessity. The introduction of PARP1 inhibitors into therapy, almost ten …

Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant

R Jia, J Zhang, J Zhang, C Bertagnin, A Bonomini… - Molecules, 2022 - mdpi.com
To address drug resistance to influenza virus neuraminidase inhibitors (NAIs), a series of
novel boron-containing N-substituted oseltamivir derivatives were designed and …